Advertisement
Screener

Portola Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Liability

Portola Pharmaceuticals, Inc. Increase (Decrease) in Contract with Customer, Liability

Portola Pharmaceuticals, Inc. reported Increase (Decrease) in Contract with Customer, Liability of -$491.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2020-05-11

  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2020-03-31 was -$491.00K, a 262.05% decline year-over-year.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2019-12-31 was $515.00K.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2019-09-30 was -$222.00K.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2019-06-30 was -$956.00K, a 212.60% decline year-over-year.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2019 was -$360.00K.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was -$1.29M.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2017 was -$15.80M, a 184.26% decline from fiscal 2016.
  • Portola Pharmaceuticals, Inc. increase (decrease) in contract with customer, liability for fiscal 2016 was $18.75M.
Period endIncrease (Decrease) in Contract with Customer, Liability 3 monthIncrease (Decrease) in Contract with Customer, Liability 6 monthIncrease (Decrease) in Contract with Customer, Liability 9 monthIncrease (Decrease) in Contract with Customer, Liability 12 month
2020-03-31-$491.00K
10-Q · filed 2020-05-11
$24.00K
derived: sum of 2 quarters · filed 2020-05-11
-$198.00K
derived: sum of 3 quarters · filed 2020-05-11
-$1.15M
derived: sum of 4 quarters · filed 2020-05-11
2019-12-31$515.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$293.00K
derived: sum of 2 quarters · filed 2020-02-28
-$663.00K
derived: sum of 3 quarters · filed 2020-02-28
-$360.00K
10-K · filed 2020-02-28
2019-09-30-$222.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$1.18M
derived: sum of 2 quarters · filed 2019-11-05
-$875.00K
10-Q · filed 2019-11-05
-$1.98M
derived: sum of 4 quarters · filed 2020-05-11
2019-06-30-$956.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$653.00K
10-Q · filed 2019-08-07
-$1.76M
derived: sum of 3 quarters · filed 2020-05-11
-$4.44M
derived: sum of 4 quarters · filed 2020-05-11
2019-03-31$303.00K
10-Q · filed 2020-05-11
-$805.00K
derived: sum of 2 quarters · filed 2020-05-11
-$3.48M
derived: sum of 3 quarters · filed 2020-05-11
-$2.63M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31-$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
-$3.79M
derived: sum of 2 quarters · filed 2020-02-28
-$2.94M
derived: sum of 3 quarters · filed 2020-02-28
-$1.29M
10-K · filed 2020-02-28
2018-09-30-$2.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$1.83M
derived: sum of 2 quarters · filed 2019-11-05
-$180.00K
10-Q · filed 2019-11-05
-$3.23M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$849.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$2.50M
10-Q · filed 2019-08-07
-$554.00K
derived: sum of 3 quarters · filed 2020-02-28
-$4.38M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$1.65M
10-Q · filed 2019-05-08
-$1.40M
derived: sum of 2 quarters · filed 2020-02-28
-$5.23M
derived: sum of 3 quarters · filed 2020-02-28
2017-12-31-$3.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
-$6.88M
derived: sum of 2 quarters · filed 2020-02-28
-$15.80M
10-K · filed 2020-02-28
2017-09-30-$3.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$12.74M
10-Q · filed 2018-11-07
2017-06-30-$8.91M
10-Q · filed 2018-08-09
2016-12-31$18.75M
10-K · filed 2019-03-01